Scientech Research LLC’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Scientech Research LLC’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,240	Closed	-$288K	–	786
2024 Q1	$288K	Buy	+8,240	New	+$300K	0.15%	288

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Scientech Research LLC's INBX Position: Q2 2024 in Review

Scientech Research LLC sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 8,240 shares — an estimated $288K sold.

Scientech Research LLC first reported a position in INBX in Q1 2024 and held it in 1 quarter. The position peaked at $288K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Scientech Research LLC reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Scientech Research LLC sold 8,240 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $288K.
Scientech Research LLC first reported a position in Inhibrx, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Scientech Research LLC's Inhibrx, Inc. Common Stock position peaked at $288K in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Scientech Research LLC's 13F filing for Q2 2024, filed 14 Aug 2024.